H.R. 5467 · 119th Congress (2025–2027)
PAAT Act
To amend title XVIII of the Social Security Act to require coverage of drugs for autoimmune diseases and certain blood disorders under Medicare part D.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 5467’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Julie Johnson (D-TX-32)
- Cosponsors
5 cosponsors
1 original · 4 later
- Rep. Mike Kennedy (R-UT-3)· Original · Sep 18, 2025
- Rep. Sarah Elfreth (D-MD-3)· Later · Oct 10, 2025
- Rep. Emanuel Cleaver (D-MO-5)· Later · Oct 17, 2025
- Rep. Josh Gottheimer (D-NJ-5)· Later · Nov 19, 2025
- Del. Eleanor Holmes Norton (D-DC)· Later · Nov 19, 2025
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
PAAT Act
Display title, Short title · Introduced in House
Patient Access to Autoimmune Treatments Act
Short title · Introduced in House
To amend title XVIII of the Social Security Act to require coverage of drugs for autoimmune diseases and certain blood disorders under Medicare part D.
Official title · Introduced in House